Maplight Therapeutics

This study tests an experimental oral medication, ML-007C-MA, in 307 adults hospitalized with schizophrenia who are having a sudden worsening of psychosis. The goal is to see if the drug reduces symptoms like hallucinations and delusions better than a placebo. Participants take t…

This study tested an experimental drug called ML-004 in 168 adolescents and adults with autism spectrum disorder to see if it could improve social communication skills. Participants were randomly assigned to receive either the drug or a placebo for several weeks. The main goal wa…